We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




Innovation Enhances Low-Dose Imaging Procedures

By HospiMedica International staff writers
Posted on 26 Mar 2013
Automated dose monitoring and optimization will help increase patient care by empowering clinicians to reduce and amend dose levels.

The DoseMap feature, available on the GE Healthcare (Chalfont St. More...
Giles, United Kingdom) Innova IGS 5x0 platform, displays local cumulative patient dose levels all along the examination, and offers the operator the chance to change the local dose delivery by modifying the dose setting and/or gantry angulation when reaching given thresholds of a procedure. The expected benefits include helping the operator avoid potentially exceeding the local dose threshold, and assisting clinicians to better monitor dose levels.

Other solutions to lower dose levels offered by GE include ASiR, a lower dose image reconstruction technology enabler, which has been installed on more than 1,800 GE computerized tomography (CT) systems worldwide that has provided more than 20 million scans to date; Veo, a model-based iterative reconstruction that enables CT imaging under 1 millisievert with profound clarity; and CT Dose Check, a feature that helps users manage exposure prescan, through notifications and alerts to operators.

“Cardiovascular disease is a complex, whole-body disease managed at multiple levels in the healthcare continuum,” said Tom Gentile, president and CEO of GE Healthcare’s Healthcare Systems. “GE Healthcare can help our customers to ensure efficient, targeted, and connected cardiovascular care with integrated solutions. Our cardiovascular portfolio is designed to help clinicians and their cardiac patients focus on affordability, improved quality, and increased access around the world.”

Another dose reduction innovation available from GE is the exclusive Motion FREEdom with intelligent coronary motion correction, a platform that enables fast, high performance imaging with expanded capabilities for use in the emergency room (ER). The system represents a solution to virtually “freeze” coronary motion in higher heart rate coronary CT exams by the introduction of SnapShot Freeze, an intelligent motion correction feature that precisely determines actual vessel position and intelligently correct the effects of motion during cardiac CT exams.

Related Links:

GE Healthcare



New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.